WHO launches campaign to halt smoking in Africa


LONDON (Reuters) - The World Health Organization launched a campaign on Friday to try to stop what could become a health catastrophe caused by rapidly rising levels of smoking in Africa.


The Geneva-based agency said it wanted to stop tobacco from becoming as prevalent in Africa as it is in other parts of the world and would set up a regional hub in 2010 for health experts to work with governments to introduce anti-smoking policies.

"Tobacco use is the most preventable cause of illness and death," the WHO's expert on non-communicable diseases, Ala Alwan, said in a statement.

"Unchecked, it will kill more than 8 million people per year by 2030, with more than 80 percent of those deaths occurring in developing countries. Although tobacco use is less prevalent in Africa than in other regions of the world, that will change unless we act."

The American Cancer Society said last month that rising smoking levels in Africa -- which are expected to double in some areas -- could cause a pandemic.

Some African countries have introduced smoking bans but most have not. Experts fear that if current trends continue, the continent faces a surge in cancer cases and deaths from smoking.

Tobacco use is a key risk factor for heart attacks, strokes, cancers, diabetes and asthma and other chronic diseases -- which together account for 60 percent of all deaths worldwide.

Such diseases are expected to account for 46 percent of deaths in Africa by 2030, up from 25 percent in 2004.

Alwan said smoking was not just a health problem, but an economic one too.

"Tobacco breeds poverty, killing people in their most productive years," he said. "It consumes family and health-care budgets -- money spent on tobacco products is money not spent on such essentials as education, food and medicine."

A spokesman for the WHO said the regional hub would be set up in an existing medical, health or university institution in the region but the location had not yet been decided.

Experts at the center will work with governments to help them introduce and enforce policies such as smoke-free pubic places and bans on tobacco advertising and sponsorship for sports and other events. The work will be financed in part by a $10-million grant from the Bill & Melinda Gates Foundation.

(Reporting by Kate Kelland; editing by Robin Pomeroy)
Share

Cervarix Proves Effective Against HPV for Over 6 Years

| 0 comments

WEDNESDAY, Dec. 2 (HealthDay News) -- The human papillomavirus (HPV) vaccine Cervarix protects women from infection for longer than six years, new research has found.

The vaccine guards against the two types of HPV (HPV-16 and HPV-18) most commonly associated with cervical cancer.

The study looked at nearly 800 women, aged 15 to 25, with a normal cervical profile and no evidence of HPV infection at the start of the trial. There were 393 women who received the Cervarix vaccine and 383 who received an inactive placebo. Every six months for 6.4 years, the women were tested for HPV DNA.

The researchers found that vaccine efficacy against 12-month persistent infection with HPV-16/18 remained 100 percent during the study period. Vaccine efficacy against incident infection with HPV-16/18 was 95 percent. Antibody concentrations against HPV-16/18 in vaccinated women remained at least several-fold higher than would be found after natural HPV infection, the study authors noted.

Cervarix also protected women against incident infection with HPV-31 and HPV-45, which "are among the types most frequently associated with cervical cancer after HPV-16 and HPV-18, and are responsible for 10 percent of all cervical cancer cases," wrote Dr. Cosette Wheeler, of the Health Sciences Center at the University of New Mexico, and colleagues.

The study was released online Dec. 2 in advance of publication in an upcoming print issue of The Lancet.

"Although further assessment is necessary to confirm long-term vaccine effects, in view of the data from our study, we expect protection to continue for many more years," the researchers concluded.

Cervarix, from GlaxoSmithKline, received U.S. Food and Drug Administration approval in October.

More information
The U.S. National Cancer Institute has more about HPV vaccines.
Share

TND Top Keywords




SUPPORT CHILDREN IN DISTRESS & PROTECT CHILDREN'S RIGHTS (ASSOCIATION FOR ASSURED FUTURE)

| 0 comments


In the past, children were all too often viewed more as property than people. Many victories for children's rights have been won in the last 100 years, such as child labor laws, protecting children from having to work long hours in unsafe conditions; public education, allowing all children to have access to learning; and laws preventing child abuse. But tthere is still much to do in protecting children's rights around the world.


Millions of Africa's children are denied the simple joys of childhood - love, protection and often life itself.

In the past, children were all too often viewed more as property than people.

Many victories for children's rights have been won in the last 100 years, such as child labor laws, protecting children from having to work long hours in unsafe conditions; public education, allowing all children to have access to learning; and laws preventing child abuse. But tthere is still much to do in protecting children's rights around the world.

For any significant change to be possible, it will require each one of us to start thinking of children, as citizens with the same rights that we consider our due.

We,at AFAF Association For Assured Future believe that ALL children are equal, with equal rights.

We invite you to voice your views, thoughts and feelings about children and their rights. Thank you! You can visit us at www.afafng.org or call +2348081525901 you can also reach us at assuredfuturengo@yahoo.com

Share

Nursing Care Plan : Risk for infection secondary to unavailability of staff physicians to perform task to the client and environmental factor that the client is exposed to as manifested by pus formation


(click the picture to enlarge)